Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mason

Showing results (731-740 of 754) with videos related to

Pageof 76
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Nature Communications|June 18, 2021
Tick extracellular vesicles enable arthropod feeding and promote distinct outcomes of bacterial infectionAdela S Oliva Chávez, Xiaowei Wang, Liron Marnin, et al.
Arxiv|December 18, 2023
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor NetworkAriana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 76

Showing results (731-740 of 754) with videos related to

Sort By:
Pageof 76
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Nature Communications|June 18, 2021
Tick extracellular vesicles enable arthropod feeding and promote distinct outcomes of bacterial infectionAdela S Oliva Chávez, Xiaowei Wang, Liron Marnin, et al.
Arxiv|December 18, 2023
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor NetworkAriana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Gastroenterology|September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External ControlsC Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 76